Media
Dive into the latest news, press releases and reports from the Abacus Medicine Group.
Abacus Medicine Group upgrades full-year outlook
Based on strong performance and growing demand in core markets the Abacus Medicine Group is upgrading the full-year outlook for 2023.
Sustainability Report 2022: The Abacus Medicine Group continued to work with sustainability and ESG within 6 focus programs
A materiality assessment, an official Diversity & Inclusion strategy, and workshops for increased awareness of sustainability and ESG across the company were among the concrete initiatives in the Group’s strategic sustainability efforts.
Annual Report 2022: Profitability focus pays off for the Abacus Medicine Group
Increasing profitability was a declared target for the Group for 2022 and this was successfully achieved. Based on strong performance especially in the parallel distribution business EBITDA grew 58% to a record level of EUR 26.2 million.
Milestone: 1,000,000,000 euros
The Abacus Medicine Group has reached another major milestone. Today, the combined revenue of the group’s business units has surpassed 1,000,000,000 euros for the first time.
Abacus Medicine wins 12th Gazelle Award
The Gazelle is awarded by Børsen to the fastest-growing Danish companies of the year. Abacus Medicine has won its 12th Gazelle Award. This makes Abacus
Allan Dinesen appointed new Chief Operating Officer of the Abacus Medicine Group
Allan Dinesen becomes the fifth member of an expanded Chief Executive Management Team. The Abacus Medicine Group has appointed Allan Dinesen as its new Chief
Our press releases are intended for the media
To comply with applicable regulation, product-related press releases are removed from our website within three weeks of publication. They are available upon request.
